Search research articles
Contact Us
Filters
Showing results (431-440 of 7,859) with videos related to
Page
of 786
Sort By:
Contraception
|
June 9, 2009
Subcutaneous DMPA vs. intramuscular DMPA: a 2-year randomized study of contraceptive efficacy and bone mineral density
Andrew M Kaunitz, Philip D Darney, Douglas Ross, et al.
Contraception
|
June 9, 2009
Efficacy and safety of a low-dose combined oral contraceptive containing drospirenone 3 mg and ethinylestradiol 20 mcg in a 24/4-day regimen
László Hernádi, Joachim Marr, Dietmar Trummer, et al.
Contraception
|
June 9, 2009
Efficacy of an oral contraceptive containing EE 0.03 mg and CMA 2 mg (Belara) in moderate acne resolution: a randomized, double-blind, placebo-controlled Phase III trial
Gerd Plewig, William J Cunliffe, Natascha Binder, et al.
Contraception
|
June 9, 2009
Selective effect of chlormadinone acetate on brain allopregnanolone and opioids content
Nicola Pluchino, Elena Lenzi, Sara Merlini, et al.
Contraception
|
June 9, 2009
First impressions: what are preclinical medical students in the US and Canada learning about sexual and reproductive health?
Jody Steinauer, Flynn LaRochelle, Marta Rowh, et al.
Contraception
|
June 9, 2009
Serum levonorgestrel levels and endometrial thickness during extended use of the levonorgestrel-releasing intrauterine system
Maria M Hidalgo, Creusa Hidalgo-Regina, M Valeria Bahamondes, et al.
Contraception
|
June 9, 2009
Cervical preparation with laminaria tents improves induction-to-delivery interval in second- and third-trimester medical termination of pregnancy
Chafika Mazouni, Nadège Vejux, Jean-Pierre Menard, et al.
Contraception
|
August 1, 1990
A multicentre phase III comparative study of two hormonal contraceptive preparations NET-OEN (50 mg) + E2 valerate (5 mg) given every month and NET-OEN (200 mg) given every 2 months as intramuscular injection--a report of 12-month study. Indian Council of Medical Research Task Force on Hormonal Contraception
Contraception
|
May 16, 2009
Intrauterine devices for adolescents: a systematic review
Elizabeth I Deans, David A Grimes
Contraception
|
May 16, 2009
Bleeding pattern, tolerance and patient satisfaction with a drospirenone-containing oral contraceptive evaluated in 3488 women in Europe, the Middle East and Canada
Jan S Endrikat, Nikola P Milchev, Aleksandra Kapamadzija, et al.
Page
of 786
Search research articles
Search
Showing results (431-440 of 7,859) with videos related to
Sort By:
Page
of 786
Contraception
|
June 9, 2009
Subcutaneous DMPA vs. intramuscular DMPA: a 2-year randomized study of contraceptive efficacy and bone mineral density
Andrew M Kaunitz, Philip D Darney, Douglas Ross, et al.
Contraception
|
June 9, 2009
Efficacy and safety of a low-dose combined oral contraceptive containing drospirenone 3 mg and ethinylestradiol 20 mcg in a 24/4-day regimen
László Hernádi, Joachim Marr, Dietmar Trummer, et al.
Contraception
|
June 9, 2009
Efficacy of an oral contraceptive containing EE 0.03 mg and CMA 2 mg (Belara) in moderate acne resolution: a randomized, double-blind, placebo-controlled Phase III trial
Gerd Plewig, William J Cunliffe, Natascha Binder, et al.
Contraception
|
June 9, 2009
Selective effect of chlormadinone acetate on brain allopregnanolone and opioids content
Nicola Pluchino, Elena Lenzi, Sara Merlini, et al.
Contraception
|
June 9, 2009
First impressions: what are preclinical medical students in the US and Canada learning about sexual and reproductive health?
Jody Steinauer, Flynn LaRochelle, Marta Rowh, et al.
Contraception
|
June 9, 2009
Serum levonorgestrel levels and endometrial thickness during extended use of the levonorgestrel-releasing intrauterine system
Maria M Hidalgo, Creusa Hidalgo-Regina, M Valeria Bahamondes, et al.
Contraception
|
June 9, 2009
Cervical preparation with laminaria tents improves induction-to-delivery interval in second- and third-trimester medical termination of pregnancy
Chafika Mazouni, Nadège Vejux, Jean-Pierre Menard, et al.
Contraception
|
August 1, 1990
A multicentre phase III comparative study of two hormonal contraceptive preparations NET-OEN (50 mg) + E2 valerate (5 mg) given every month and NET-OEN (200 mg) given every 2 months as intramuscular injection--a report of 12-month study. Indian Council of Medical Research Task Force on Hormonal Contraception
Contraception
|
May 16, 2009
Intrauterine devices for adolescents: a systematic review
Elizabeth I Deans, David A Grimes
Contraception
|
May 16, 2009
Bleeding pattern, tolerance and patient satisfaction with a drospirenone-containing oral contraceptive evaluated in 3488 women in Europe, the Middle East and Canada
Jan S Endrikat, Nikola P Milchev, Aleksandra Kapamadzija, et al.
Page
of 786